In glioblastoma, Korfi et al. suggested that a higher concentration of aprepitant (35 μM) is capable of reducing ROS production while increasing the enzymatic activity of superoxidase dismutase (SOD) and catalase [38]. Here, SOD1 is linked to glioblastoma.